Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s557802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Hsing-Yu Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Antifungal Agents, Triazoles, Mycoses. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
ORCID-Profile: Fang-Ju Lin, Chien-Chih Wu
Zitieren
APA
Lin, H. Y., Hu, S. C., Pai, T. Y., Lin, F. J., & Wu, C. C. (2025). Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s557802
Vancouver
Lin HY, Hu SC, Pai TY, Lin FJ, Wu CC. Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s557802
BibTeX
@article{Lin2025,
author = {Lin, Hsing-Yu and Hu, Shu-Chen and Pai, Tsung-Yu and Lin, Fang-Ju and Wu, Chien-Chih},
title = {Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s557802}
}
EUVIMED